MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2013 Financial Results Shenzhen,

[Mindray Announces First Quarter 2013 Financial Results Shenzhen, China May6, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March31, 2013. Highlights for First Quarter 2013 - Net revenues totaled $242.1 million. Chinales were strong]

MR [Mindray Medical International] 20-F: (Original Filing)

[INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 28 ITEM 4A. UNRESOLVED STAFF COMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 76 ITEM 7.] [LIST OF SUBSIDIARIES • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Shenzhen Mindray Investment & Development Co., Ltd. , incorporated in the People’s Republic of China • Shenzhen Mindray Software Technology Co., Ltd. , incorporated in the People’s Republic of China • Nanjing Mindray Bio-Medical Electronics Co., Ltd. , incorporated in the People’s] [MINDRAY MEDICAL INTERNATIONAL LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Code of Business Conduct and Ethics Contents I. Statement of Mission, Vision and Pillars II. Principle on Compliance of Law III. Principle on Conflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure and Confidentiality VI. Principle on Honesty and Fair Trading VII. Principle on Protection of] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Director, President and Chief Executive Officer Alex Lung Chief Financial Officer EX-13.1 6 d463253dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 8, 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY

[INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 28 ITEM 4A. UNRESOLVED STAFF COMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 76 ITEM 7.] [LIST OF SUBSIDIARIES • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Shenzhen Mindray Investment & Development Co., Ltd. , incorporated in the People’s Republic of China • Shenzhen Mindray Software Technology Co., Ltd. , incorporated in the People’s Republic of China • Nanjing Mindray Bio-Medical Electronics Co., Ltd. , incorporated in the People’s] [MINDRAY MEDICAL INTERNATIONAL LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Code of Business Conduct and Ethics Contents I. Statement of Mission, Vision and Pillars II. Principle on Compliance of Law III. Principle on Conflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure and Confidentiality VI. Principle on Honesty and Fair Trading VII. Principle on Protection of] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Director, President and Chief Executive Officer Alex Lung Chief Financial Officer EX-13.1 6 d463253dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 8, 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

MR [Mindray Medical International] 20-F: (Original Filing)

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF STYLE="font-family:Times New Roman" SIZE="2"> BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2"> I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; STYLE="font-family:Times New Roman" SIZE="2">2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF STYLE="font-family:Times New Roman" SIZE="2"> BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2"> I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; STYLE="font-family:Times New Roman" SIZE="2">2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to]

MR [Mindray Medical International] 20-F: INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF

[INTRODUCTION 1 PART I. 3 ITEM1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY 28 ITEM4A. UNRESOLVED STAFFMMENTS 50 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES] [LIST OF SUBSIDIARIES Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Shenzhen Mindray Investment& Development ,orporated in the Peoples Republic of China Shenzhen Mindray Software Technology ,orporated in the Peoples Republic of China Nanjing Mindray Bio-Medical Electronics ,orporated in the Peoples Republic of China] [MINDRAY MEDICAL INTERNATIONAL LIMITEDDE OF BUSINESSNDUCT AND ETHICSde of Businessnduct and Ethicsntents I. Statement of Mission, Vision and Pillars II. Principle onmpliance of Law III. Principle onnflict of Interest IV. Principle on Insider Trading V. Principle on Information Disclosure andnfidentiality VI. Principle on Honesty and Fair Trading] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION Li Xiting Director,PresidentandChiefExecutiveOfficerex Lung Chief Financial Officer EX-13.1 d463253dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No.333-178896) of Mindray Medical International Limited of our reportdated April 8, 2013 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form20-F. Wesonsent to the reference to us]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2012 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 25, 2013 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012. Highlights for Fourth Quarter and Full Year 2012 • Full]

By | 2016-03-04T05:17:29+00:00 February 25th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces 2012 Fourth Quarter and Full Year

[Mindray Announces 2012 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 25, 2013 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012. Highlights for Fourth Quarter and Full Year 2012 • Full]

By | 2016-03-04T05:18:40+00:00 February 25th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2012 Fourth Quarter and Full Year Results STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China, Feb. 25, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December31, 2012.]

By | 2016-02-08T04:13:38+00:00 February 25th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces 2012 Fourth Quarter and Full Year

[Mindray Announces 2012 Fourth Quarter and Full Year Results STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China, Feb. 25, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December31, 2012.]

By | 2016-02-08T04:14:31+00:00 February 25th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar